Chautauqua Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$35.3M Sell
324,861
-14,869
-4% -$1.7M 11.16% 2
2015
Q3
$33.9M Buy
339,730
+63,731
+23% +$6.93M 11.16% 2
2015
Q2
$31.5M Buy
275,999
+9,014
+3% +$1.09M 7.63% 5
2015
Q1
$27.9M Buy
+266,985
New +$28.4M 7.08% 5

Other funds holding CLB

Chautauqua Capital Management's CLB Position: Q4 2015 in Review

Chautauqua Capital Management reduced its Core Laboratories (CLB) stake by 4.4% in Q4 2015, selling an estimated $1.7M and leaving 324,861 shares worth $35.3M. The position accounts for 11.16% of the portfolio, ranked #2.

Chautauqua Capital Management first reported a position in CLB in Q1 2015 and has held it in 4 quarters since. 371 funds tracked by Wall St. Rank hold CLB as of Q4 2015.

  • Chautauqua Capital Management held 324,861 shares of Core Laboratories worth $35.3M as of Q4 2015.
  • Chautauqua Capital Management sold 14,869 Core Laboratories shares in Q4 2015, an estimated $1.7M.
  • Core Laboratories made up 11.16% of Chautauqua Capital Management's portfolio in Q4 2015, its #2 holding.
  • Chautauqua Capital Management first reported a position in Core Laboratories in Q1 2015 and has held it in 4 quarters since.
  • 371 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2015.

Based on Chautauqua Capital Management's 13F filing for Q4 2015, filed 22 Jan 2016.